Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

NETWORK × Cardiotoxicity × Proton Therapy × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neoplasms 2 Brain Neoplasms 2 Thymus Neoplasms 1 Thymoma 1 Prostatic Neoplasms 1 Pancreatic Neoplasms 1 Meningioma 1 Gliosarcoma 1 Glioblastoma 1 Central Nervous System Neoplasms 1 Cardiotoxicity 1 Carcinoma, Non-Small-Cell Lung 1 Breast Neoplasms 1

Interventions

Razoxane 4 Doxorubicin 4 Dexrazoxane 4 Vincristine 3 Etoposide 3 Radiotherapy 2 Prednisone 2 Methotrexate 2 Granulocyte Colony-Stimulating Factor 2 Filgrastim 2 Bleomycin 2 hydrocortisone hemisuccinate 1 Watchful Waiting 1 Trastuzumab 1 Proton Therapy 1 Observation 1 Mercaptopurine 1 Leucovorin 1 Ifosfamide 1 Hydrocortisone 1 Enalapril 1 Cytarabine 1 Cyclophosphamide 1 Cisplatin 1 Carvedilol 1 Asparaginase 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04822077 2021-03-30

PROTHYM

Swedish Lung Cancer Study Group

Phase NA Recruiting

Thymoma, Thymus Neoplasms, Cardiotoxicity

Data powered by HemOnc (CC BY 4.0) Colophon ⚡